GADD45B
Growth arrest and DNA damage-inducible protein GADD45 beta
Also known as: DKFZP566B133, GA45B_HUMAN, GADD45BETA, MYD118
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75293
- Gene
- GADD45B
- Ensembl
- ENSG00000099860
- Chromosome
- 19
- Canonical length
- 160 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The genes in this group respond to environmental stresses by mediating activation of the p38/JNK pathway. This activation is mediated via their proteins binding and activating MTK1/MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. The function of these genes or their protein products is involved in the regulation of growth and apoptosis. These genes are regulated by different mechanisms, but they are often coordinately expressed and can function cooperatively in inhibiting cell growth. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
160 residues, UniProt reviewed canonical sequence.
>O75293|GADD45B
1 MTLEELVACD NAAQKMQTVT AAVEELLVAA QRQDRLTVGV YESAKLMNVD PDSVVLCLLA
61 IDEEEEDDIA LQIHFTLIQS FCCDNDINIV RVSGMQRLAQ LLGEPAETQG TTEARDLHCL
121 LVTNPHTDAW KSHGLVEVAS YCEESRGNNQ WVPYISLQERLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GADD45B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 538 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 538 nTPM
- liver: 384 nTPM
- heart muscle: 364 nTPM
- adipose tissue: 328 nTPM
- lung: 322 nTPM
- bone marrow: 304 nTPM
Single-cell type
- vascular smooth muscle cells: 2,537 nCPM
- epididymal basal cells: 2,078 nCPM
- breast myoepithelial cells: 1,950 nCPM
- smooth muscle cells: 1,588 nCPM
- endometrial luminal cells: 1,493 nCPM
- breast lactating cells: 1,201 nCPM
Immune cell
- eosinophil: 132 nTPM
- neutrophil: 93 nTPM
- gdT-cell: 58 nTPM
- T-reg: 55 nTPM
- MAIT T-cell: 52 nTPM
- naive CD8 T-cell: 48 nTPM
Brain region
- cerebral cortex: 69 nTPM
- thalamus: 59 nTPM
- hypothalamus: 56 nTPM
- medulla oblongata: 52 nTPM
- choroid plexus: 50 nTPM
- spinal cord: 50 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0.21
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell differentiation
- positive regulation of apoptotic process
- positive regulation of JNK cascade
- positive regulation of p38MAPK cascade
- regulation of cell cycle
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GADD45B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GADD45B as an antibody target. Whether an autoantibody or antibody against GADD45B could matter depends on whether native GADD45B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GADD45B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GADD45B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...